Navigation Links
Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b
Date:9/1/2008

6]** 1.8 [0.4-5.1]

60mg 15.2 [10.0-21.8]** 2.2 [0.6-5.4]

90mg 10.6 [6.2-16.6]** 2.3 [0.6-5.7]

#95% confidence interval, * p=0.005, **p<0.001, ***Major+Clinically

Relevant

About DU-176b

DU-176b is an oral anticoagulant that directly inhibits Factor Xa, a clotting factor in the blood. Daiichi Sankyo is developing DU-176b as a potential new treatment for the prevention of both arterial and venous thromboembolism.

About Daiichi Sankyo

A global pharmaceutical innovator, Daiichi Sankyo Co., Ltd., headed by President Takashi Shoda was established in 2005 through the merger of two leading Japanese pharmaceutical companies, Daiichi Pharmaceutical Co., Ltd. and Sankyo Co., Ltd. This integration created a more robust organization that allows for continuous development of novel drugs that enrich the quality of life for patients around the world. A central focus of Daiichi Sankyo's research and development is cardiometabolic diseases, including therapies for thrombosis, dyslipidemia, hypertension, diabetes, and acute coronary syndromes. Equally important to the company is the discovery of new medicines in the areas of infectious diseases, cancer, bone and joint diseases, and immune disorders. For more information, visit http://www.daiichisankyo.com.


'/>"/>
SOURCE Daiichi Sankyo
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
2. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
3. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
4. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)...  Sony Biotechnology Inc. ("Sony") today announced the launch of ... sorting chip.  Sony will also be exhibiting its newly rebranded ... Sorter, the EC800 flow cytometer, and new SP6800 Spectral Analyzer ... will be held at the San Diego ... , from May 20 - 22.  The ...
(Date:5/17/2013)... May 17, 2013  TechAtlas Group has announced ... competitive landscape map for the Chronic Kidney Disease ... international companies with drugs and devices currently on ... its sequelae. (Logo:  http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ... , hypertension - renal denervation , diabetic ...
(Date:5/17/2013)... May 17, 2013 Fuse Science, Inc. (OTCQB: DROP), ... that is developing new, patent-pending technologies poised to redefine how ... it will hold a business update teleconference and webcast for ... , 2013 at 4:30 PM ET. Fuse ... host the call and will be joined by ...
Breaking Medicine Technology:Sony Delivers New Technology for Science to CYTO 2013 2TechAtlas Group Releases Innovative Chronic Kidney Disease Landscape Map 2Fuse Science, Inc. to Hold Business Update Webcast and Teleconference on May 22nd 2
... , CHICAGO, Nov. 30 A ... (CT) receive unindicated and unnecessary additional image acquisition resulting ... presented today at the annual meeting of the Radiological ... responsibility of all physicians who work with ionizing radiation ...
... IOWA CITY, Iowa and ST. LOUIS, Nov. 29 ... for the advanced analysis of pulmonary diseases, and Veran ... interventional oncology therapies, announced the companies have signed a ... endobronchial lung navigation and biopsy system. , "Veran,s ...
Cached Medicine Technology:Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 2Unindicated CT Series Result in Unnecessary Radiation Exposure for Patients 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 2VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 4
(Date:5/19/2013)... These molecular diagnostics market reports ... Japan, Italy, Germany and France:, ... practice, as well as key economic, regulatory, demographic, ... during the next five years. ,     An ... test formats, detection methodologies, trends in testing automation ...
(Date:5/19/2013)... Amenia, NY (PRWEB) May 19, 2013 ... According to the newest American Veterinary Medical Association ... two-thirds of American dog owners consider their dog a ... owners who had said as much five years earlier. ... total dollar value of the national income dedicated to ...
(Date:5/19/2013)... Vegas Hotel Escapes, the premier ... the launch it's all new vacation packages for the ... 5/19/2013. Consumers traveling to Las Vegas will be pleased ... VegasHotelEscapes.com's website. Travelers will be pleased to know that ... , Vegas Hotel Escapes specializes in helping consumers ...
(Date:5/19/2013)... Passages Malibu, the leading non-12 step, ... this week the launch of a “Sobriety, Health, and ... channels. “We are always looking for new ways ... get feedback regarding sobriety, what’s working for people, and ... the Passages Addiction Treatment Centers located in ...
(Date:5/19/2013)... Florida (PRWEB) May 19, 2013 ... market access, is pleased to unveil a new and ... environment that provides a powerful array of real-time communication ... in the US and abroad. , HE-Xpo is powered ... offer attendees the look and feel of being at ...
Breaking Medicine News(10 mins):Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3
... of different varieties of lipids (fatty molecules) in the ... better and earlier prediction of diseases such as diabetes, ... annual conference of the European Society of Human Genetics ... first study, Dr. Joanne Curran from the Texas Biomedical ...
... get the flu, they often land in the hospital gasping ... previously unknown biological pathway explaining why influenza induces asthma attacks. ... the journal Nature Immunology , reveal that influenza activates ... cells presenting a completely new set of drug targets ...
... , SATURDAY, May 28 (HealthDay News) -- It,s start ... of picnics and barbecues. But, even though many people are ... they may still be making mistakes that can serve up a ... the American Dietetic Association and ConAgra Foods, Home Food Safety program ...
... -- Contrary to the belief of some television producers, ... kids enjoy them more, a new study reveals. , ... shows now contain some degree of violent content, Indiana ... identified more with non-violent characters. "Violence isn,t the ...
... Maryland researcher Vivian Hoffmann has studied poverty, migration, and ... first-hand experience with issues facing women in the developing ... Bill & Melinda Gates Foundation, she will lead a ... light on women,s menstrual practices, needs, and product demands ...
... the University of British Columbia,s Faculties of Medicine, ... clinical trial aimed at improving outcomes for patients ... Funded by the Terry Fox Research Institute, the ... Trial, or COOLS Study, involves universities and hospitals ...
Cached Medicine News:Health News:New advances in lipid genetics lead to better detection and prevention of major diseases 2Health News:New advances in lipid genetics lead to better detection and prevention of major diseases 3Health News:New advances in lipid genetics lead to better detection and prevention of major diseases 4Health News:Why does flu trigger asthma? 2Health News:Don't Let Food Poisoning Spoil Your Picnic 2Health News:Violence Doesn't Make TV Shows More Enjoyable for Kids 2Health News:Talking about the taboo: Women's menstrual practices and sanitation in Africa 2Health News:UBC researchers to lead $4.7-million study on early-stage oral cancer 2
West lacrimal cannula blunt tip with side port....
Shahinian lachrymal cannula, blunt tapered with side port....
West lacrimal cannula, blunt tip, 0.3 mm side opening....
The first easy-to use peroxide system offers proven efficacy that's pure and simple. The convenience of a multi-purpose cleaner/rinse in one bottle. Added power of peroxide in the other bottle....
Medicine Products: